Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 60

1.
2.

Pharmacokinetics and bioavailability of a metformin/glyburide tablet administered alone and with food.

Marathe PH, Arnold ME, Meeker J, Greene DS, Barbhaiya RH.

J Clin Pharmacol. 2000 Dec;40(12 Pt 2):1494-502.

PMID:
11185672
3.

Effect of altered gastric emptying and gastrointestinal motility on metformin absorption.

Marathe PH, Wen Y, Norton J, Greene DS, Barbhaiya RH, Wilding IR.

Br J Clin Pharmacol. 2000 Oct;50(4):325-32.

4.
5.

Disposition of radiolabeled ifetroban in rats, dogs, monkeys, and humans.

Dockens RC, Santone KS, Mitroka JG, Morrison RA, Jemal M, Greene DS, Barbhaiya RH.

Drug Metab Dispos. 2000 Aug;28(8):973-80.

PMID:
10901709
6.

Pharmacokinetics of buspirone following oral administration to rhesus monkeys.

Marathe PH, Shen F, Markham P, Greene DS.

J Pharm Pharmacol. 1999 May;51(5):601-7.

PMID:
10411220
7.

The effects of age and gender on the pharmacokinetics of irbesartan.

Vachharajani NN, Shyu WC, Smith RA, Greene DS.

Br J Clin Pharmacol. 1998 Dec;46(6):611-3.

8.

In vivo evaluation of the absorption and gastrointestinal transit of avitriptan in fed and fasted subjects using gamma scintigraphy.

Marathe PH, Sandefer EP, Kollia GE, Greene DS, Barbhaiya RH, Lipper RA, Page RC, Doll WJ, Ryo UY, Digenis GA.

J Pharmacokinet Biopharm. 1998 Feb;26(1):1-20.

PMID:
9773390
9.

Evaluation of the effect of food on the pharmacokinetics of avitriptan.

Marathe PH, Greene DS, Kollia GD, Barbhaiya RH.

Biopharm Drug Dispos. 1998 Sep;19(6):381-94.

PMID:
9737819
10.

Oral bioavailability and disposition characteristics of irbesartan, an angiotensin antagonist, in healthy volunteers.

Vachharajani NN, Shyu WC, Chando TJ, Everett DW, Greene DS, Barbhaiya RH.

J Clin Pharmacol. 1998 Aug;38(8):702-7.

PMID:
9725545
11.

Lack of effect of food on the oral bioavailability of irbesartan in healthy male volunteers.

Vachharajani NN, Shyu WC, Mantha S, Park JS, Greene DS, Barbhaiya RH.

J Clin Pharmacol. 1998 May;38(5):433-6.

PMID:
9602956
12.

Assessment of effect of food, gender, and intra-subject variability in the pharmacokinetics of avitriptan.

Marathe PH, Greene DS, Lee JS, Barbhaiya RH.

Biopharm Drug Dispos. 1998 Apr;19(3):153-7.

PMID:
9569997
13.

A pharmacokinetic interaction study of avitriptan and propranolol.

Marathe PH, Greene DS, Kollia GD, Barbhaiya RH.

Clin Pharmacol Ther. 1998 Mar;63(3):367-78.

PMID:
9542480
14.

The effects of age and gender on the single dose pharmacokinetics of avitriptan administered to healthy volunteers.

Marathe PH, Greene DS, Kollia GD, Barbhaiya RH.

J Clin Pharmacol. 1997 Oct;37(10):937-45.

PMID:
9505985
15.

Effects of age, gender, and diurnal variation on the steady-state pharmacokinetics of BMS-181101, an antidepressant, in healthy subjects.

Srinivas NR, Shyu WC, Gleason C, Schuster A, Greene DS, Barbhaiya RH.

Clin Pharmacol Ther. 1997 Oct;62(4):408-16.

PMID:
9357392
16.

Clinical pharmacokinetics of nefazodone.

Greene DS, Barbhaiya RH.

Clin Pharmacokinet. 1997 Oct;33(4):260-75. Review.

PMID:
9342502
17.

Lack of effect of food on the steady state pharmacokinetics of BMS-181101, an antidepressant, in healthy subjects.

Srinivas NR, Shyu WC, Lee J, Greene DS, Barbhaiya RH.

Biopharm Drug Dispos. 1997 Oct;18(7):585-93.

PMID:
9330779
18.
19.

Disposition of [14C]avitriptan in rats and humans.

Marathe PH, Greene DS, Barbhaiya RH.

Drug Metab Dispos. 1997 Jul;25(7):881-8.

PMID:
9224783
20.

The pharmacokinetics of butorphanol and its metabolites at steady state following nasal administration in humans.

Vachharajani NN, Shyu WC, Greene DS, Barbhaiya RH.

Biopharm Drug Dispos. 1997 Apr;18(3):191-202.

PMID:
9113342
21.
22.
23.

The lack effect of food on the bioavailability of nefazodone tablets.

Dockens RC, Greene DS, Barbhaiya RH.

Biopharm Drug Dispos. 1996 Mar;17(2):135-43.

PMID:
8907720
24.

A pharmacokinetic study of intravenous CTLA4Ig, a novel immunosuppressive agent, in mice.

Srinivas NR, Weiner RS, Shyu WC, Calore JD, Tritschler D, Tay LK, Lee JS, Greene DS, Barbhaiya RH.

J Pharm Sci. 1996 Mar;85(3):296-8.

PMID:
8699332
25.
26.

Investigation of pharmacokinetic and pharmacodynamic interactions after coadministration of nefazodone and haloperidol.

Barbhaiya RH, Shukla UA, Greene DS, Breul HP, Midha KK.

J Clin Psychopharmacol. 1996 Feb;16(1):26-34.

PMID:
8834415
27.

A study of the effect of age and gender on the pharmacokinetics of nefazodone after single and multiple doses.

Barbhaiya RH, Buch AB, Greene DS.

J Clin Psychopharmacol. 1996 Feb;16(1):19-25.

PMID:
8834414
28.

Pharmacokinetics and pharmacodynamics of CTLA4lg (BMS-188667), a novel immunosuppressive agent, in monkeys following multiple doses.

Srinivas NR, Weiner RS, Warner G, Shyu WC, Davidson T, Fadrowski CG, Tay LK, Lee JS, Greene DS, Barbhaiya RH.

J Pharm Sci. 1996 Jan;85(1):1-4.

PMID:
8926572
29.

Pharmacokinetics, absolute bioavailability, and disposition of [14C]nefazodone in humans.

Barbhaiya RH, Dandekar KA, Greene DS.

Drug Metab Dispos. 1996 Jan;24(1):91-5.

PMID:
8825195
30.
31.
32.

Coadministration of nefazodone and benzodiazepines: IV. A pharmacokinetic interaction study with lorazepam.

Greene DS, Salazar DE, Dockens RC, Kroboth P, Barbhaiya RH.

J Clin Psychopharmacol. 1995 Dec;15(6):409-16.

PMID:
8748429
33.

Coadministration of nefazodone and benzodiazepines: III. A pharmacokinetic interaction study with alprazolam.

Greene DS, Salazar DE, Dockens RC, Kroboth P, Barbhaiya RH.

J Clin Psychopharmacol. 1995 Dec;15(6):399-408.

PMID:
8748428
34.

Pharmacokinetics of CTLA4Ig (BMS-188667), a novel immunosuppressive agent, following intravenous and subcutaneous administration to mice.

Srinivas NR, Shyu WC, Weiner RS, Tay LK, Greene DS, Barbhaiya RH.

J Pharm Sci. 1995 Dec;84(12):1488-9. No abstract available.

PMID:
8748333
36.

Absorption and presystemic metabolism of nefazodone administered at different regions in the gastrointestinal tract of humans.

Marathe PH, Salazar DE, Greene DS, Brennan J, Shukla UA, Barbhaiya RH.

Pharm Res. 1995 Nov;12(11):1716-21.

PMID:
8592675
37.

Coadministration of nefazodone and benzodiazepines: II. A pharmacokinetic interaction study with triazolam.

Barbhaiya RH, Shukla UA, Kroboth PD, Greene DS.

J Clin Psychopharmacol. 1995 Oct;15(5):320-6.

PMID:
8830062
38.

Safety, tolerance, and preliminary pharmacokinetics of nefazodone after administration of single and multiple oral doses to healthy adult male volunteers: a double-blind, phase I study.

Barbhaiya RH, Marathe PH, Greene DS, Mayol RF, Shukla UA, Gammans RR, Pittman KA, Robinson D.

J Clin Pharmacol. 1995 Oct;35(10):974-84.

PMID:
8568015
39.

Single- and multiple-dose pharmacokinetics of nefazodone in patients with hepatic cirrhosis.

Barbhaiya RH, Shukla UA, Natarajan CS, Behr DA, Greene DS, Sainati SM.

Clin Pharmacol Ther. 1995 Oct;58(4):390-8.

PMID:
7586930
40.

Lack of interaction between nefazodone and cimetidine: a steady state pharmacokinetic study in humans.

Barbhaiya RH, Shukla UA, Greene DS.

Br J Clin Pharmacol. 1995 Aug;40(2):161-5.

41.

Steady-state pharmacokinetics of nefazodone in subjects with normal and impaired renal function.

Barbhaiya RH, Brady ME, Shukla UA, Greene DS.

Eur J Clin Pharmacol. 1995;49(3):229-35.

PMID:
8666000
42.
43.

Diabetes and job performance: an empirical investigation.

Greene DS, Geroy GD.

Diabetes Educ. 1993 Jul-Aug;19(4):293-8.

PMID:
8370332
44.

Single-dose pharmacokinetics of piperacillin and tazobactam in patients with renal disease.

Johnson CA, Halstenson CE, Kelloway JS, Shapiro BE, Zimmerman SW, Tonelli A, Faulkner R, Dutta A, Haynes J, Greene DS, et al.

Clin Pharmacol Ther. 1992 Jan;51(1):32-41.

PMID:
1310077
45.

Addressing attitudes during diabetes education: suggestions from adult education.

Greene DS, Beaudin BP, Bryan JM.

Diabetes Educ. 1991 Nov-Dec;17(6):470-3.

PMID:
1935555
46.

Pharmacokinetics of YTR830H and piperacillin after intravenous coadministration.

Cheung WK, Greene DS, Kuye O, Shin K, Tonelli AP, Houston A, Hibberd M, Faulkner RD, Silber BM.

J Chemother. 1989 Jul;1(4 Suppl):507-8. No abstract available.

PMID:
16312506
47.

Pharmacokinetics of YTR830H in healthy human subjects.

Cheung WK, Greene DS, Kuye O, Smith MP, Holder A, Fernandez P, Houston A, Faulkner RD, Silber BM.

J Chemother. 1989 Jul;1(4 Suppl):505-6. No abstract available.

PMID:
16312505
48.

The effect of age on ranitidine pharmacokinetics.

Greene DS, Szego PL, Anslow JA, Hooper JW.

Clin Pharmacol Ther. 1986 Mar;39(3):300-5.

PMID:
3948468
49.

Comparative single dose and steady-state pharmacokinetics of bevantolol in young and elderly subjects.

Selen A, Kinkel AW, Darke AC, Greene DS, Welling PG.

Eur J Clin Pharmacol. 1986;30(6):699-704.

PMID:
2876899
50.

Supplemental Content

Loading ...
Support Center